Seeing Is Believing
MRVI is currently covered by 4 analysts with an average price target of $5. This is a potential downside of $2.07 (-29.28%) from yesterday's end of day stock price of $7.07.
Maravai Lifesciences Holdings's activity chart (see below) currently has 154 price targets and 110 ratings on display. The stock rating distribution of MRVI is 60% BUY and 40% HOLD.
Analysts average stock forecasts to be materialized ratio is 61.61% with an average time for these price targets to be met of 122.24 days.
Highest price target for MRVI is $8, Lowest price target is $3, average price target is $5.
Most recent stock forecast was given by DAN BRENNAN from UBS on 09-Sep-2026. First documented stock forecast 13-Dec-2020.
Currently out of the existing stock ratings of MRVI, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Aug-2024
$8
$1.21 (17.82%)
$11
1 months 14 days ago
(09-Sep-2026)
2/3 (66.67%)
$1.05 (15.11%)
36
Buy Since 15-Dec-2020
$5.5
$-0.72 (-11.58%)
$4.5
5 months 15 days ago
(08-May-2026)
3/3 (100%)
$0.65 (13.40%)
80
Hold Since 25-Feb-2026
$3
$-3.79 (-55.82%)
7 months 27 days ago
(25-Feb-2026)
6/11 (54.55%)
$-0.56 (-15.73%)
121
Buy Since 15-Dec-2020
$4
$-2.22 (-35.69%)
$5
11 months 16 days ago
(07-Nov-2025)
7/14 (50%)
$1.13 (39.37%)
181
Buy Since 07-Dec-2022
$5
$-1.22 (-19.61%)
$13
1 years 2 months 11 days ago
(12-Aug-2025)
1/13 (7.69%)
$2.31 (85.87%)
297
What is MRVI (Maravai Lifesciences Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on MRVI (Maravai Lifesciences Holdings)?
Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings)?
Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings)?
Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings)?